{"disease":{"id":"clonal-hematopoiesis-of-indeterminate-potential","name":"clonal hematopoiesis of indeterminate potential"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02958462","title":"Pre-myeloid Cancer and Bone Marrow Failure Clinic Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04987268","title":"CHIP and Residual Cardiovascular Event Tendency After Smoking Cessation","phase":"","overall_status":"COMPLETED","enrollment_count":1029,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT04102423","title":"CHIP/CCUS Natural History Protocol","phase":"","overall_status":"RECRUITING","enrollment_count":306,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07362966","title":"Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Shenyang Northern Hospital","has_results":false},{"nct_id":"NCT06097663","title":"A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05246813","title":"Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)","phase":"","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Imelda Hospital, Bonheiden","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}